Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
Get a real-life look at what’s happening on the ground in Haiti from Dr. Pierre Rouzier, Sports Medicine doctor at University of Massachusetts Amherst. In the aftermath of…
EW YORK (Reuters Health) – Annual testing for Chlamydia trachomatis doesn’t prevent many cases of pelvic inflammatory disease (PID), according to a prospective U.K. study published in BMJ…
NEW YORK (Reuters Health) – In new recommendations for the management of vulvodynia, the British Society for the Study of Vulval Diseases Guideline Group stresses a team approach…
NEW YORK (Reuters Health) – Accelerated radiation therapy is more effective than conventional fractionation for squamous cell carcinoma of the head and neck (HNSCC), but complications of treatment…
NEW YORK (Reuters Health) – For treatment of chronic painful shoulder, hyaluronate injections are a safe and effective alternative to other conservative methods, according to a meta-analysis by…
NEW YORK (Reuters Health) – When should cystic fibrosis patients with hemoptysis or pneumothorax be hospitalized? When should they receive antibiotics? When should a chest tube be placed…
NEW YORK (Reuters Health) – Ultrasound can be useful in the work-up of infants with a first urinary tract infection, researchers from Sweden report in the May issue…
NEW YORK (Reuters Health) – Upgrading traditional 2 chamber cardiac pacemakers to modern 3 chamber pacemakers — cardiac resynchronization therapy (CRT) devices — improves left ventricular ejection fraction…
NEW YORK (Reuters Health) – Polyps smaller than 10 mm that are detected with CT colonography (CTC) screening are very unlikely to contain high-grade dysplasia or malignancy, a…
NEW YORK (Reuters Health) – Concomitant chemoradiation is better than sequential therapy for improving survival with locally advanced non-small-cell lung cancer (NSCLC), according to a patient-level meta-analysis reported…
